Anders Svensson
Fortuna: 266 845 $ al 30/06/2026
Fortuna: 266 845 $ al 30/06/2026
Anders Svensson is the founder of C Dr. Svensson Consulting, founded in 2019.
Dr. Svensson is currently Director at TikoMed AB and Independent Director at Cereno Scientific AB since 2018.
Formerly, Dr. Svensson was Vice President at AstraZeneca PLC.
Dr. Svensson earned a doctorate from the University of Gothenburg.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 31/12/2024 | 488.200 ( 0,16 % ) | 266 845 $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| CERENO SCIENTIFIC AB | Director/Miembro de la Junta | 23/10/2018 |
TikoMed AB
TikoMed AB Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Director/Miembro de la Junta | - |
| Empresas | Cargo | Fin |
|---|---|---|
| ASTRAZENECA PLC | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
AstraZeneca PLC
AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
University of Gothenburg
University of Gothenburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TikoMed AB
TikoMed AB Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Cereno Scientific AB
Cereno Scientific AB Pharmaceuticals: MajorHealth Technology Researches and develops pharmaceutical products | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.